You are here
Chemdiv, Inc.
UEI: WZKETC8NCBF1
# of Employees: 450
HUBZone Owned: No
Socially and Economically Disadvantaged: No
Woman Owned: No
Award Charts
Award Listing
-
Discovery of Small Molecule hACC2 Inhibitors for Treatment of Obesity
Amount: $100,000.00DESCRIPTION (provided by applicant): Acetyl-CoA carboxylase (ACC) is a key enzyme of fatty acid metabolism required for the addition of CO2 to acetyl-CoA to make malonyl-CoA. In mammals, malonyl-CoA s ...
SBIRPhase I2007Department of Health and Human Services National Institutes of Health -
Identification of Novel ACTH Small Molecule Antagonists
Amount: $750,086.00DESCRIPTION (provided by applicant): Development of drugs based on the MC2R antagonists will directly benefit children with CAH and Cushing's diseases, and will help us to understand MC2R's role in me ...
STTRPhase II2006Department of Health and Human Services National Institutes of Health -
Identification of Novel ACTH Small Molecule Antagonists
Amount: $750,086.00DESCRIPTION (provided by applicant): Development of drugs based on the MC2R antagonists will directly benefit children with CAH and Cushing's diseases, and will help us to understand MC2R's role in me ...
SBIRPhase II2006Department of Health and Human Services National Institutes of Health -
DRUG DISCOVERY FOR TREATMENT OF OBESITY
Amount: $100,000.00The goal of this research project is to define the structure and radioactive label for ligands that will permit quantitative measurement of serotonin transporter (5-HTT) sites in living brain by exter ...
STTRPhase I2004Department of Health and Human Services National Institutes of Health -
Identification of Novel ACTH small molecule Antagonists
Amount: $100,000.00DESCRIPTION (provided by applicant): The production of adrenal gland hormones, including cortisol and androgens, is regulated by pituitary ACTH (adrenocorticotropin hormone), which acts via the melano ...
STTRPhase I2004Department of Health and Human Services National Institutes of Health
